Overview
Fangfang Li practices practicing medicine in Zhengzhou, China.
Their clinical expertise encompasses Fountain Syndrome, Isolated Duane Retraction Syndrome, Duane-Radial Ray Syndrome, Lung Cancer, and Endovascular Embolization.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Fangfang Z. Li
Is Fangfang Z. Li a top-rated expert for Fountain Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Fangfang Z. Li is classified as an Experienced expert for Fountain Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Fangfang Z. Li participate in research or clinical trials?
Yes. Fangfang Z. Li has published 9 articles and abstracts on conditions like Fountain Syndrome. You can view a list of Fangfang Z. Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Duane-Radial Ray Syndrome
- Endovascular Embolization
- Fountain SyndromeLi isExperienced. Learn about Fountain Syndrome.
- Isolated Duane Retraction Syndrome
- Lung CancerLi isExperienced. Learn about Lung Cancer.